Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study.
dc.contributor.author | Gómez-Martínez, Carlos | |
dc.contributor.author | Babio, Nancy | |
dc.contributor.author | Júlvez, Jordi | |
dc.contributor.author | Becerra-Tomás, Nerea | |
dc.contributor.author | Martínez-González, Miguel Á | |
dc.contributor.author | Corella, Dolores | |
dc.contributor.author | Castañer, Olga | |
dc.contributor.author | Romaguera, Dora | |
dc.contributor.author | Vioque, Jesús | |
dc.contributor.author | Alonso-Gómez, Ángel M | |
dc.contributor.author | Wärnberg, Julia | |
dc.contributor.author | Martínez, José A | |
dc.contributor.author | Serra-Majem, Luís | |
dc.contributor.author | Estruch, Ramón | |
dc.contributor.author | Tinahones, Francisco J | |
dc.contributor.author | Lapetra, José | |
dc.contributor.author | Pintó, Xavier | |
dc.contributor.author | Tur, Josep A | |
dc.contributor.author | López-Miranda, José | |
dc.contributor.author | Bueno-Cavanillas, Aurora | |
dc.contributor.author | Gaforio, José J | |
dc.contributor.author | Matía-Martín, Pilar | |
dc.contributor.author | Daimiel, Lidia | |
dc.contributor.author | Martín-Sánchez, Vicente | |
dc.contributor.author | Vidal, Josep | |
dc.contributor.author | Vázquez, Clotilde | |
dc.contributor.author | Ros, Emilio | |
dc.contributor.author | Dalsgaard, Søren | |
dc.contributor.author | Sayón-Orea, Carmen | |
dc.contributor.author | Sorlí, José V | |
dc.contributor.author | de la Torre, Rafael | |
dc.contributor.author | Abete, Itziar | |
dc.contributor.author | Tojal-Sierra, Lucas | |
dc.contributor.author | Barón-López, Francisco J | |
dc.contributor.author | Fernández-Brufal, Noelia | |
dc.contributor.author | Konieczna, Jadwiga | |
dc.contributor.author | García-Ríos, Antonio | |
dc.contributor.author | Sacanella, Emilio | |
dc.contributor.author | Bernal-López, M Rosa | |
dc.contributor.author | Santos-Lozano, José M | |
dc.contributor.author | Razquin, Cristina | |
dc.contributor.author | Alvarez-Sala, Andrea | |
dc.contributor.author | Goday, Albert | |
dc.contributor.author | Zulet, M Angeles | |
dc.contributor.author | Vaquero-Luna, Jessica | |
dc.contributor.author | Diez-Espino, Javier | |
dc.contributor.author | Cuenca-Royo, Aida | |
dc.contributor.author | Fernández-Aranda, Fernando | |
dc.contributor.author | Bulló, Mònica | |
dc.contributor.author | Salas-Salvadó, Jordi | |
dc.date.accessioned | 2025-01-07T13:36:32Z | |
dc.date.available | 2025-01-07T13:36:32Z | |
dc.date.issued | 2021-10-29 | |
dc.description.abstract | Type 2 diabetes has been linked to greater cognitive decline, but other glycemic parameters such as prediabetes, diabetes control and treatment, and HOMA-IR and HbA1c diabetes-related biomarkers have shown inconsistent results. Furthermore, there is limited research assessing these relationships in short-term studies. Thus, we aimed to examine 2-year associations between baseline diabetes/glycemic status and changes in cognitive function in older participants at high risk of cardiovascular disease. We conducted a 2-year prospective cohort study (n=6,874) within the framework of the PREDIMED-Plus study. The participants (with overweight/obesity and metabolic syndrome; mean age 64.9 years; 48.5% women) completed a battery of 8 cognitive tests, and a global cognitive function Z-score (GCF) was estimated. At baseline, participants were categorized by diabetes status (no-diabetes, prediabetes, and Prediabetes status was unrelated to cognitive decline. However, compared to participants without diabetes, those with ≥5-year diabetes duration had greater reductions in GCF (β=-0.11 (95%CI -0.16;-0.06)], as well as in processing speed and executive function measurements. Inverse associations were observed between baseline HOMA-IR and changes in GCF [β=-0.0094 (95%CI -0.0164;-0.0023)], but also between HbA1c levels and changes in GCF [β=-0.0085 (95%CI -0.0115, -0.0055)], the Mini-Mental State Examination, and other executive function tests. Poor diabetes control was inversely associated with phonologic fluency. The use of insulin treatment was inversely related to cognitive function as measured by the GCF [β=-0.31 (95%CI -0.44, -0.18)], and other cognitive tests. Insulin resistance, diabetes status, longer diabetes duration, poor glycemic control, and insulin treatment were associated with worsening cognitive function changes in the short term in a population at high cardiovascular risk. http://www.isrctn.com/ISRCTN89898870, identifier ISRCTN: 89898870. | |
dc.identifier.doi | 10.3389/fendo.2021.754347 | |
dc.identifier.issn | 1664-2392 | |
dc.identifier.pmc | PMC8586462 | |
dc.identifier.pmid | 34777250 | |
dc.identifier.pubmedURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC8586462/pdf | |
dc.identifier.unpaywallURL | https://www.frontiersin.org/articles/10.3389/fendo.2021.754347/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/25680 | |
dc.journal.title | Frontiers in endocrinology | |
dc.journal.titleabbreviation | Front Endocrinol (Lausanne) | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Reina Sofía | |
dc.organization | Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.organization | SAS - Hospital Universitario Virgen de la Victoria | |
dc.organization | SAS - Hospital Universitario Regional de Málaga | |
dc.organization | Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA) | |
dc.organization | SAS - D.S.A.P. Sevilla | |
dc.page.number | 754347 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Observational Study | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | cognitive function | |
dc.subject | diabetes duration | |
dc.subject | glycated (glycosylated) hemoglobin | |
dc.subject | insulin resistance | |
dc.subject | prediabetes | |
dc.subject | type 2 diabetes | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Cognition | |
dc.subject.mesh | Cognitive Dysfunction | |
dc.subject.mesh | Female | |
dc.subject.mesh | Glucose Metabolism Disorders | |
dc.subject.mesh | Glycemic Control | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Hypoglycemic Agents | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Prospective Studies | |
dc.title | Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 12 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- PMC8586462.pdf
- Size:
- 549.93 KB
- Format:
- Adobe Portable Document Format
Collections
SAS - Hospital Universitario Reina Sofía
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto de Investigación Biosanitaria de Granada (ibsGRANADA)
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - D.S.A.P. Sevilla
Load more Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto de Investigación Biosanitaria de Granada (ibsGRANADA)
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - D.S.A.P. Sevilla